<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Malar J</journal-id>
      <journal-id journal-id-type="iso-abbrev">Malar. J</journal-id>
      <journal-title-group>
        <journal-title>Malaria Journal</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1475-2875</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24350652</article-id>
      <article-id pub-id-type="pmc">3878349</article-id>
      <article-id pub-id-type="publisher-id">1475-2875-12-451</article-id>
      <article-id pub-id-type="doi">10.1186/1475-2875-12-451</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Failure of malaria chemoprophylaxis with mefloquine in an oversize traveller to Mozambique</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" id="A1">
          <name>
            <surname>Gobbi</surname>
            <given-names>Federico</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>federico.gobbi@sacrocuore.it</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Rossanese</surname>
            <given-names>Andrea</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>andrea.rossanese@sacrocuore.it</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Buonfrate</surname>
            <given-names>Dora</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>dora.buonfrate@sacrocuore.it</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Angheben</surname>
            <given-names>Andrea</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>andrea.angheben@sacrocuore.it</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Lunardi</surname>
            <given-names>Gianluigi</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>gianluigi.lunardi@sacrocuore.it</email>
        </contrib>
        <contrib contrib-type="author" id="A6">
          <name>
            <surname>Bisoffi</surname>
            <given-names>Zeno</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>zeno.bisoffi@sacrocuore.it</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Centre for Tropical Diseases, Sacro Cuore-Don Calabria Hospital, Verona, Negrar, Italy</aff>
      <aff id="I2"><label>2</label>Oncology Department, Sacro Cuore-Don Calabria Hospital, Verona, Negrar, Italy</aff>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>18</day>
        <month>12</month>
        <year>2013</year>
      </pub-date>
      <volume>12</volume>
      <fpage>451</fpage>
      <lpage>451</lpage>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>7</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>16</day>
          <month>12</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2013 Gobbi et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Gobbi et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.malariajournal.com/content/12/1/451"/>
      <abstract>
        <p>A case of failure of mefloquine prophylaxis in an oversize traveller, who correctly took the drug. This case seems to be attributed to mefloquine resistance, however it is suggested that mefloquine dosage should be modulated by body weight, as is already indicated by some authorities.</p>
      </abstract>
      <kwd-group>
        <kwd>Failure</kwd>
        <kwd>Mefloquine</kwd>
        <kwd>Chemoprophylaxis</kwd>
        <kwd>Malaria</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>The correct dosage for mefloquine in anti-malarial chemoprophylaxis is 5&#xA0;mg/kg [<xref ref-type="bibr" rid="B1">1</xref>]. The vast majority of international [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>] and national [<xref ref-type="bibr" rid="B4">4</xref>] guidelines on malaria prevention suggests a prophylactic dose of 250&#xA0;mg per week in adult travellers. However, regardless the product label, some national Travel Medicine Societies, such as the Swiss and the Austrian ones, suggest to modulate the drug dosage by body weight (Table&#xA0;<xref ref-type="table" rid="T1">1</xref>) [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]: 1 &#xBD; tablet per week for patients weighing&#x2009;&gt;&#x2009;90&#xA0;kg, two tablets per week for the patients weighing&#x2009;&gt;&#x2009;120&#xA0;kg. The dosage issue concerns not only the overweight, but also the low weight travellers. Those weighing&#x2009;&lt;&#x2009;60&#xA0;kg may poorly tolerate a whole tablet of mefloquine per week [<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B9">9</xref>].</p>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>Dosage of mefloquine tablet (250&#xA0;mg) in Swiss/Austrian malaria prophylaxis recommendations</p>
        </caption>
        <table frame="hsides" rules="groups" border="1">
          <colgroup>
            <col align="center"/>
            <col align="center"/>
          </colgroup>
          <thead valign="top">
            <tr>
              <th align="center">
                <bold>&gt; 120&#xA0;kg</bold>
              </th>
              <th align="center">
                <bold>2 tablets (twice weekly on tablet: e.g. Mon &amp; Thu)</bold>
              </th>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <td align="center" valign="bottom">&gt; 90&#xA0;kg<hr/></td>
              <td align="center" valign="bottom">1 and &#xBD; tablets (twice weekly on tablet: e.g. Mon &amp; Thu)<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">&gt; 60&#xA0;kg<hr/></td>
              <td align="center" valign="bottom">1 tablet<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">40-60&#xA0;kg<hr/></td>
              <td align="center" valign="bottom">&#xBE; tablet<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">20-40&#xA0;kg<hr/></td>
              <td align="center" valign="bottom">&#xBD; tablet<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">10-20&#xA0;kg<hr/></td>
              <td align="center" valign="bottom">&#xBC; tablet<hr/></td>
            </tr>
            <tr>
              <td align="center">&lt; 10&#xA0;kg</td>
              <td align="center">5&#xA0;mg /kg</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>A case is presented of mefloquine failure in an oversize traveller, that was initially attributed to insufficient dosage.</p>
      <sec>
        <title>Case presentation</title>
        <p>A 50-year-old Italian patient was admitted to the Centre for Tropical Diseases (CTD) with fever (39&#xB0;C) and diarrhoea since three days. He reported having visited many Catholic missions over several years (he is a priest) in sub-Saharan Africa, Asia and Latin America. The average length of stay was between 10 and 14&#xA0;days. He had been vaccinated against yellow fever, hepatitis A and B, and typhoid fever. From 20<sup>th</sup> to 31<sup>st</sup> March 2012, he had travelled to Mozambique, regularly taking malaria chemoprophylaxis with mefloquine, one tablet (250&#xA0;mg) weekly, starting one week before travelling and continuing for four weeks after return: he took the last tablet on 24<sup>th</sup> April. He presented to CTD on May 18<sup>th</sup> 2012. His weight was 144&#xA0;kg. He had no history of alcohol, tobacco or illicit drugs abuse. He was not under any long-term medication. The hearth rate was 90 beats per minute and the blood pressure 140/70&#xA0;mm Hg. Physical examination was unremarkable, except for a distended abdomen. Quantitative buffy coat (QBC), antigen malarial test and blood smears resulted positive for <italic>Plasmodium falciparum</italic> malaria, with a parasitaemia of 0.13% (6330 /&#x3BC;l). The blood tests showed 7430 WBC/&#x3BC;l, C reactive protein 142&#xA0;mg/L. The patient was treated with artemether (tablet 50&#xA0;mg), eight tablets the first day, then three tablets/day until the fifth day, followed by four tablets of sulphamethoxypyrazine/pyrimethamine 500&#xA0;mg/25&#xA0;mg (artemisinin-based combination artemisinin-based combination therapies were not yet available). After two days of treatment, blood films resulted negative and remained so at follow-up, one month later.</p>
        <p>Whole blood and plasma mefloquine concentrations were retrospectively evaluated on cryo- preserved (-80&#xB0;C) samples taken on admission (25&#xA0;days after the last mefloquine intake), by high pressure liquid chromatography (HPLC) coupled with ultraviolet diode-array detection [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>].</p>
        <p>Whole blood and plasma mefloquine concentrations were 516 and 320&#xA0;ng/mL, respectively.</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Despite a correct anti-malarial chemoprophylaxis, the patient developed <italic>P. falciparum</italic> malaria. Therefore, it was concluded that either the strain of <italic>P. falciparum</italic> was resistant to mefloquine, or its dose was insufficient according to the patient&#x2019;s body weight. At first, the failure was attributed to an insufficient dosage according to the patient&#x2019;s weight (144&#xA0;kg), but later mefloquine concentration was assessed on pre-treatment plasma and blood samples that had been stored.</p>
      <p>The mefloquine level in the patient&#x2019;s bloodstream at admission was within the expected range, considering the breakthrough mefloquine levels &gt;620&#xA0;ng/ml and a half-life of 21&#xA0;days (Product information Lariam&#xAE;, Roche, the Netherlands). Considering these data, <italic>P. falciparum</italic> resistance to mefloquine was more probable, despite the limitation of a single point in time determination.</p>
      <p>A review of literature was performed to collect the characteristics and probable causes of reported cases of failure of mefloquine prophylaxis. PubMed was searched using the following keywords: mefloquine, chemoprophylaxis, failure, Africa. Thirteen papers were retrieved [<xref ref-type="bibr" rid="B12">12</xref>-<xref ref-type="bibr" rid="B24">24</xref>], describing a total of 31 cases (Table&#xA0;<xref ref-type="table" rid="T2">2</xref>). Only three cases were reported in the last 15&#xA0;years, while the others were reported between 1990 and 1998. In most of the cases (25/31) the infection had been acquired in West Africa, in six cases in East Africa (one each in Malawi, Tanzania, Madagascar, Mozambique, and two in Somalia). Six patients were females and 25 males; six were children and 25 were adults between 18 and 50&#xA0;years of age. Three patients developed <italic>P. falciparum</italic> malaria while in the endemic country, 28 patients after return. In the latter group, 16 travellers became ill within four weeks after return (still under prophylaxis) and 12 developed the disease after the last dose of mefloquine. The median onset of symptoms after return was 28&#xA0;days (range 3&#x2013;91&#xA0;days). In all cases resistance to mefloquine was presumed, although for some of them drug concentration in plasma was not available.</p>
      <table-wrap position="float" id="T2">
        <label>Table 2</label>
        <caption>
          <p>Papers describing mefloquine prophylaxis failure in travellers to Africa</p>
        </caption>
        <table frame="hsides" rules="groups" border="1">
          <colgroup>
            <col align="left"/>
            <col align="center"/>
            <col align="center"/>
            <col align="center"/>
            <col align="center"/>
            <col align="center"/>
          </colgroup>
          <thead valign="top">
            <tr>
              <th align="left">
                <bold>Author</bold>
              </th>
              <th align="center">
                <bold>Age</bold>
              </th>
              <th align="center">
                <bold>Sex</bold>
              </th>
              <th align="center">
                <bold>Country of infection</bold>
              </th>
              <th align="center">
                <bold>Symptoms onset (before return)</bold>
              </th>
              <th align="center">
                <bold>Symptoms onset (days after return)</bold>
              </th>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <td align="left" valign="bottom">Callen (2006)<hr/></td>
              <td align="center" valign="bottom">25<hr/></td>
              <td align="center" valign="bottom">M<hr/></td>
              <td align="center" valign="bottom">Gambia<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
              <td align="center" valign="bottom">4<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Wichmann (2003)<hr/></td>
              <td align="center" valign="bottom">44<hr/></td>
              <td align="center" valign="bottom">F<hr/></td>
              <td align="center" valign="bottom">Tanzania<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
              <td align="center" valign="bottom">23<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Gary-Toussaint (2002)<hr/></td>
              <td align="center" valign="bottom">45<hr/></td>
              <td align="center" valign="bottom">M<hr/></td>
              <td align="center" valign="bottom">Senegal<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
              <td align="center" valign="bottom">41<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Gizolme (1998)<hr/></td>
              <td align="center" valign="bottom">40, 12, 9<hr/></td>
              <td align="center" valign="bottom">F, M, F<hr/></td>
              <td align="center" valign="bottom">Togo<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
              <td align="center" valign="bottom">63, 77, 91<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Lobel (1998)<hr/></td>
              <td align="center" valign="bottom">31, 22, 30, 26, 25<hr/></td>
              <td align="center" valign="bottom">M, M, M, F, M<hr/></td>
              <td align="center" valign="bottom">Niger, Sierra Leone, Cameroon, RCA<hr/></td>
              <td align="center" valign="bottom">Y<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Matteelli (1995)<hr/></td>
              <td align="center" valign="bottom">20<hr/></td>
              <td align="center" valign="bottom">M<hr/></td>
              <td align="center" valign="bottom">Mozambique<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
              <td align="center" valign="bottom">3<hr/></td>
            </tr>
            <tr>
              <td rowspan="2" align="left" valign="top">Magill (1993)<hr/></td>
              <td align="center" valign="bottom">23<hr/></td>
              <td align="center" valign="bottom">M<hr/></td>
              <td align="center" valign="bottom">Somalia<hr/></td>
              <td align="center" valign="bottom">Y<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
            </tr>
            <tr>
              <td align="center" valign="bottom">21<hr/></td>
              <td align="center" valign="bottom">M<hr/></td>
              <td align="center" valign="bottom">Somalia<hr/></td>
              <td align="center" valign="bottom">Y<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Raccurt (1991)<hr/></td>
              <td align="center" valign="bottom">3, 30, 28, 22, 40, 44, 23, 23, 27<hr/></td>
              <td align="center" valign="bottom">F, M, M, M, M, M, M, M, M<hr/></td>
              <td align="center" valign="bottom">Senegal, Burkina Faso, Niger, Nigeria, Mali, Ivory Coast, Togo<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
              <td align="center" valign="bottom">3, 4, 6, 13, 15, 19, 21, 25, 26<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Ringwald (1990)<hr/></td>
              <td align="center" valign="bottom">5, 28, 34, 37<hr/></td>
              <td align="center" valign="bottom">M, M, M, M,<hr/></td>
              <td align="center" valign="bottom">Burkina Faso, RCA, Madagascar, Togo<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
              <td align="center" valign="bottom">19, 26, 31, 32<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Ooi (1991)<hr/></td>
              <td align="center" valign="bottom">26<hr/></td>
              <td align="center" valign="bottom">M<hr/></td>
              <td align="center" valign="bottom">Malawi, Kenya<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
              <td align="center" valign="bottom">21<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Durieux (1990)<hr/></td>
              <td align="center" valign="bottom">18<hr/></td>
              <td align="center" valign="bottom">M<hr/></td>
              <td align="center" valign="bottom">Burkina Faso<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
              <td align="center" valign="bottom">58<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Gay (1990)<hr/></td>
              <td align="center" valign="bottom">6<hr/></td>
              <td align="center" valign="bottom">M<hr/></td>
              <td align="center" valign="bottom">Senegal, Ivory coast<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
              <td align="center" valign="bottom">55<hr/></td>
            </tr>
            <tr>
              <td align="left">Bricaire (1990)</td>
              <td align="center">6, 34, 40, 45, 50</td>
              <td align="center">M, M, M, M, F</td>
              <td align="center">Mali, Sierra Leone, Senegal, RCA</td>
              <td align="center">-</td>
              <td align="center">7, 30, 45, 46, 61</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>In relation to the first suspicion, there is no agreement on the need to adjust mefloquine regimen to body weight. It is worth considering this factor, though, also taking into account the lipophilic behaviour of this drug, which has an apparent volume of distribution between 13 to 40 1&#xA0;kg<sup>-1</sup> with a mean of 20 1&#xA0;kg<sup>-1</sup>. Both apparent volume of distribution and individual systemic clearance are probably influenced by body fat, thus causing different pharmacokinetic profiles [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>].</p>
      <p>In conclusion, although in this case the failure of mefloquine prophylaxis was most probably due to drug resistance, the indication given by some scientific societies that mefloquine dosage should be modulated by body weight seems reasonable and should probably be considered in new guidelines.</p>
      <sec>
        <title>Consent</title>
        <p>Written informed consent was obtained from the patient for the publication of this report.</p>
      </sec>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contribution</title>
      <p>FG, AR visited and followed-up the patient. AA and DB performed Pubmed search. FG and DB have been involved in drafting the manuscript. GL detected drug concentration. ZB and AA revised the manuscript critically for important intellectual content. All the authors have given final approval of the version to be published.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Schlagenhauf</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Adamcova</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Regep</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Schaerer</surname>
            <given-names>MT</given-names>
          </name>
          <name>
            <surname>Bansod</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rhein</surname>
            <given-names>HG</given-names>
          </name>
          <article-title>Use of mefloquine in children - a review of dosage, pharmacokinetics and tolerability data</article-title>
          <source>MalarJ</source>
          <year>2011</year>
          <volume>12</volume>
          <fpage>292</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-10-292</pub-id>
          <pub-id pub-id-type="pmid">21981927</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="book">
          <collab>CDC</collab>
          <source>Health Information for International Travel 2012</source>
          <publisher-name>The yellow book</publisher-name>
          <comment>
            <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/yellowbook">http://www.cdc.gov/yellowbook</ext-link>
          </comment>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="book">
          <collab>WHO</collab>
          <source>International travel and health</source>
          <year>2012</year>
          <publisher-name>Geneva: World Health Organization</publisher-name>
          <comment>
            <ext-link ext-link-type="uri" xlink:href="http://www.who.int/ith">http://www.who.int/ith</ext-link>
          </comment>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lalloo</surname>
            <given-names>DG</given-names>
          </name>
          <name>
            <surname>Shingadia</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Pasvol</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Chiodini</surname>
            <given-names>PL</given-names>
          </name>
          <name>
            <surname>Whitty</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Beeching</surname>
            <given-names>NJ</given-names>
          </name>
          <name>
            <surname>Hill</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Warrell</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Bannister</surname>
            <given-names>BA</given-names>
          </name>
          <article-title>UK malaria treatment guidelines</article-title>
          <source>J Infection</source>
          <year>2007</year>
          <volume>12</volume>
          <fpage>111</fpage>
          <lpage>121</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jinf.2006.12.003</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="other">
          <collab>DTG</collab>
          <source>Empfehlungen zur Malaravorbeugung</source>
          <year>2011</year>
          <comment>
            <ext-link ext-link-type="uri" xlink:href="http://www.dtg.org">http://www.dtg.org</ext-link>
          </comment>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hatz</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Nothdurft</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Malaria protection for short-term travelers</article-title>
          <source>Internist</source>
          <year>2006</year>
          <volume>12</volume>
          <issue>8</issue>
          <fpage>810</fpage>
          <lpage>812</lpage>
          <comment>814&#x2013;817</comment>
          <pub-id pub-id-type="doi">10.1007/s00108-006-1653-4</pub-id>
          <pub-id pub-id-type="pmid">16845539</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>van Riemsdijk</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Sturkenboom</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Ditters</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Tulen</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Ligthelm</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Overbosch</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Stricker</surname>
            <given-names>BH</given-names>
          </name>
          <article-title>Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquine</article-title>
          <source>Br J Clin Pharmacol</source>
          <year>2004</year>
          <volume>12</volume>
          <fpage>506</fpage>
          <lpage>512</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-2125.2003.02035.x</pub-id>
          <pub-id pub-id-type="pmid">15025750</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Schlagenhauf</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Tschopp</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Nothdurft</surname>
            <given-names>HD</given-names>
          </name>
          <name>
            <surname>Beck</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Schwartz</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Herold</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Krebs</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Veit</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Allwinn</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Steffen</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study</article-title>
          <source>BMJ</source>
          <year>2003</year>
          <volume>12</volume>
          <fpage>1078</fpage>
          <pub-id pub-id-type="doi">10.1136/bmj.327.7423.1078</pub-id>
          <pub-id pub-id-type="pmid">14604928</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ollivier</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Tifratene</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Josse</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Keundjian</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Boutin</surname>
            <given-names>JP</given-names>
          </name>
          <article-title>The relationship between body weight and tolerance to mefloquine prophylaxis in non-immune adults: results of a questionnaire-based study</article-title>
          <source>Ann Trop Med Parasitol</source>
          <year>2004</year>
          <volume>12</volume>
          <fpage>639</fpage>
          <lpage>641</lpage>
          <pub-id pub-id-type="doi">10.1179/000349804225021262</pub-id>
          <pub-id pub-id-type="pmid">15324471</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Green</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Bergqvist</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Mount</surname>
            <given-names>DL</given-names>
          </name>
          <name>
            <surname>Corbett</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>D'Souza</surname>
            <given-names>MJ</given-names>
          </name>
          <article-title>Improved validated assay for the determination of mefloquine and its carboxy metabolite in plasma, serum and whole blood using solid-phase extraction and high-performance liquid chromatography</article-title>
          <source>J Chromatogr B Biomed Sci Appl</source>
          <year>1999</year>
          <volume>12</volume>
          <fpage>159</fpage>
          <lpage>165</lpage>
          <pub-id pub-id-type="doi">10.1016/S0378-4347(99)00080-8</pub-id>
          <pub-id pub-id-type="pmid">10360435</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gutman</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Green</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Durand</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rojas</surname>
            <given-names>OV</given-names>
          </name>
          <name>
            <surname>Ganguly</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Quezada</surname>
            <given-names>WM</given-names>
          </name>
          <name>
            <surname>Utz</surname>
            <given-names>GC</given-names>
          </name>
          <name>
            <surname>Slutsker</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ruebush</surname>
            <given-names>TK</given-names>
            <suffix>2nd</suffix>
          </name>
          <name>
            <surname>Bacon</surname>
            <given-names>DJ</given-names>
          </name>
          <article-title>Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated <italic>Plasmodium falciparum</italic> malaria</article-title>
          <source>Malar J</source>
          <year>2009</year>
          <volume>12</volume>
          <fpage>58</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2875-8-58</pub-id>
          <pub-id pub-id-type="pmid">19358697</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Callen</surname>
            <given-names>EC</given-names>
          </name>
          <name>
            <surname>Church</surname>
            <given-names>CO</given-names>
          </name>
          <article-title><italic>Plasmodium falciparum</italic> malaria associated with mefloquine failure in Gambia</article-title>
          <source>Pharmacotherapy</source>
          <year>2006</year>
          <volume>12</volume>
          <fpage>1526</fpage>
          <lpage>1528</lpage>
          <pub-id pub-id-type="doi">10.1592/phco.26.10.1526</pub-id>
          <pub-id pub-id-type="pmid">16999663</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Wichmann</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Betschart</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Loscher</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Nothdurft</surname>
            <given-names>HD</given-names>
          </name>
          <name>
            <surname>Sonnenburg</surname>
            <given-names>FV</given-names>
          </name>
          <name>
            <surname>Jelinek</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Prophylaxis failure due to probable mefloquine resistant <italic>P. falciparum</italic> from Tanzania</article-title>
          <source>Acta Trop</source>
          <year>2003</year>
          <volume>12</volume>
          <fpage>63</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="doi">10.1016/S0001-706X(03)00003-2</pub-id>
          <pub-id pub-id-type="pmid">12711104</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gari-Toussaint</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pradines</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Mondain</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Keundjian</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Dellamonica</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Le Fichoux</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>[Senegal and malaria. True prophylactic failure of mefloquine] (in French)</article-title>
          <source>Presse Med</source>
          <year>2002</year>
          <volume>12</volume>
          <fpage>1136</fpage>
          <pub-id pub-id-type="pmid">12162100</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gizolme</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Receveur</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Bouzidi</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Theron</surname>
            <given-names>P</given-names>
          </name>
          <article-title>[Relative failure of mefloquine chemoprophylaxis on the occasion of a trip to Togo. 3 cases within the same family] (in French)</article-title>
          <source>Presse Med</source>
          <year>1998</year>
          <volume>12</volume>
          <fpage>1575</fpage>
          <lpage>1576</lpage>
          <pub-id pub-id-type="pmid">9819587</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lobel</surname>
            <given-names>HO</given-names>
          </name>
          <name>
            <surname>Varma</surname>
            <given-names>JK</given-names>
          </name>
          <name>
            <surname>Miani</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Green</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Todd</surname>
            <given-names>GD</given-names>
          </name>
          <name>
            <surname>Grady</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Barber</surname>
            <given-names>AM</given-names>
          </name>
          <article-title>Monitoring for mefloquine-resistant <italic>Plasmodium falciparum</italic> in Africa: implications for travelers&#x2019; health</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>1998</year>
          <volume>12</volume>
          <fpage>129</fpage>
          <lpage>132</lpage>
          <pub-id pub-id-type="pmid">9684640</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Matteelli</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Chiodera</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Castelli</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Caligaris</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Minardi</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Carosi</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Failure of mefloquine chemoprophylaxis for malaria in Mozambique</article-title>
          <source>J Travel Med</source>
          <year>1995</year>
          <volume>12</volume>
          <fpage>260</fpage>
          <lpage>261</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1708-8305.1995.tb00673.x</pub-id>
          <pub-id pub-id-type="pmid">9815405</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Magill</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Smoak</surname>
            <given-names>BL</given-names>
          </name>
          <article-title>Failure of mefloquine chemoprophylaxis for malaria in Somalia</article-title>
          <source>N Engl J Med</source>
          <year>1993</year>
          <volume>12</volume>
          <fpage>1206</fpage>
          <pub-id pub-id-type="pmid">8377800</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Raccurt</surname>
            <given-names>CP</given-names>
          </name>
          <name>
            <surname>Dumestre-Toulet</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Abraham</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Le Bras</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Brachet-Liermain</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ripert</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Failure of falciparum malaria prophylaxis by mefloquine in travelers from West Africa</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>1991</year>
          <volume>12</volume>
          <fpage>319</fpage>
          <lpage>324</lpage>
          <pub-id pub-id-type="pmid">1928565</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ooi</surname>
            <given-names>WW</given-names>
          </name>
          <article-title>Failure of mefloquine prophylaxis in east Africa</article-title>
          <source>N Engl J Med</source>
          <year>1991</year>
          <volume>12</volume>
          <issue>2</issue>
          <fpage>130</fpage>
          <pub-id pub-id-type="pmid">1984183</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Durieux</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Boibieux</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Biron</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Ringwald</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Piens</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Peyramond</surname>
            <given-names>D</given-names>
          </name>
          <article-title>[Failure of chemoprevention with mefloquine in western Africa] (in French)</article-title>
          <source>Presse Med</source>
          <year>1990</year>
          <volume>12</volume>
          <issue>33</issue>
          <fpage>1548</fpage>
          <lpage>1549</lpage>
          <pub-id pub-id-type="pmid">2146671</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ringwald</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Bartczak</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Le Bras</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bricaire</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Matheron</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bauchet</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Coulaud</surname>
            <given-names>JP</given-names>
          </name>
          <article-title>Failure of anti-malarial prophylaxis with mefloquine in Africa</article-title>
          <source>Trans R Soc Trop Med Hyg</source>
          <year>1990</year>
          <volume>12</volume>
          <fpage>348</fpage>
          <lpage>349</lpage>
          <pub-id pub-id-type="doi">10.1016/0035-9203(90)90311-2</pub-id>
          <pub-id pub-id-type="pmid">2260164</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gay</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Binet</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Bustos</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Rouveix</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Danis</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Roy</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gentilini</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Mefloquine failure in child contracting falciparum malaria in West Africa</article-title>
          <source>Lancet</source>
          <year>1990</year>
          <volume>12</volume>
          <fpage>120</fpage>
          <lpage>121</lpage>
          <pub-id pub-id-type="doi">10.1016/0140-6736(90)90597-X</pub-id>
          <pub-id pub-id-type="pmid">1967412</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bricaire</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Gay</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Caumes</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Datry</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bustos</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Felix</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Paris</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Danis</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gentilini</surname>
            <given-names>M</given-names>
          </name>
          <article-title>[Failure of prevention of malaria by mefloquine in West Africa] (in French)</article-title>
          <source>Ann Med Onterne</source>
          <year>1990</year>
          <volume>12</volume>
          <issue>6</issue>
          <fpage>512</fpage>
          <lpage>514</lpage>
        </mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Karbwang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>White</surname>
            <given-names>NJ</given-names>
          </name>
          <article-title>Clinical pharmacokinetics of mefloquine</article-title>
          <source>Clin Pharmacokinet</source>
          <year>1990</year>
          <volume>12</volume>
          <fpage>264</fpage>
          <lpage>279</lpage>
          <pub-id pub-id-type="doi">10.2165/00003088-199019040-00002</pub-id>
          <pub-id pub-id-type="pmid">2208897</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Palmer</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Holliday</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Brogden</surname>
            <given-names>RN</given-names>
          </name>
          <article-title>Mefloquine: a review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy</article-title>
          <source>Drugs</source>
          <year>1993</year>
          <volume>12</volume>
          <fpage>430</fpage>
          <lpage>475</lpage>
          <pub-id pub-id-type="pmid">7682911</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
